Cardiovascular Screening Programme
Advanced cardiac and vascular assessment to detect heart disease risk years before symptoms develop, enabling targeted prevention of heart attack and stroke.
Why Cardiovascular Screening Matters
Cardiovascular disease remains the leading cause of death globally, responsible for one in three deaths. Heart attacks and strokes often occur suddenly, with the first symptom being a fatal event. Yet cardiovascular disease develops silently over decades, creating opportunities for early detection and prevention.
Standard cardiovascular risk assessment relies on basic cholesterol tests and risk calculators that miss many individuals at high risk. Research demonstrates that nearly half of heart attacks occur in people classified as "low risk" by traditional methods. Advanced screening reveals hidden cardiovascular disease, allowing intervention before irreversible damage occurs.
At Longevity Centre London, our cardiovascular screening programme combines cutting-edge biomarker analysis, vascular function testing, and cardiac imaging to provide a comprehensive assessment of your heart and vascular health. We identify atherosclerosis, arterial dysfunction, and cardiac abnormalities at their earliest stages, when prevention strategies are most effective.
Benefits of Advanced Cardiovascular Screening
Early Detection
Identify atherosclerosis, arterial stiffness, and cardiac dysfunction years before symptoms develop, when intervention is most effective.
Prevent Heart Attack & Stroke
Detect and address cardiovascular risks before they progress to life-threatening events like myocardial infarction or cerebrovascular accident.
Comprehensive Risk Assessment
Go beyond basic cholesterol tests with advanced biomarkers, imaging, and functional assessments that reveal your true cardiovascular health status.
Personalised Prevention
Develop targeted interventions based on your specific risk profile, from lifestyle modifications to medical therapies and regenerative treatments.
Comprehensive Cardiovascular Assessment
Our screening programme examines multiple dimensions of cardiovascular health, from blood biomarkers to advanced imaging studies.
Advanced Lipid Analysis
- •Apolipoprotein B (ApoB) - superior cardiovascular risk marker
- •Lipoprotein(a) - inherited cardiovascular risk factor
- •LDL particle number and size distribution
- •HDL functionality testing
- •Triglyceride-rich lipoprotein analysis
- •Remnant cholesterol measurement
Inflammatory & Metabolic Markers
- •High-sensitivity C-reactive protein (hs-CRP)
- •Lipoprotein-associated phospholipase A2 (Lp-PLA2)
- •Myeloperoxidase (MPO)
- •Oxidised LDL (ox-LDL)
- •Homocysteine levels
- •Insulin resistance markers (HOMA-IR)
Cardiac Biomarkers
- •High-sensitivity troponin (hs-Tn)
- •N-terminal pro-B-type natriuretic peptide (NT-proBNP)
- •Growth differentiation factor 15 (GDF-15)
- •Galectin-3
- •ST2 (suppression of tumorigenicity 2)
Vascular Function Assessment
- •Endothelial function testing (flow-mediated dilation)
- •Arterial stiffness measurement (pulse wave velocity)
- •Central blood pressure analysis
- •Ankle-brachial index (ABI)
Advanced Cardiac Imaging
- •Coronary artery calcium (CAC) scoring via CT
- •Carotid intima-media thickness (CIMT) ultrasound
- •Echocardiography with strain imaging
- •Cardiac MRI (when clinically indicated)
- •CT coronary angiography (CTCA) for selected patients
Thrombosis & Coagulation
- •Fibrinogen levels
- •D-dimer
- •Platelet function testing
- •Factor V Leiden and prothrombin mutations
- •Antithrombin, protein C, protein S
The Screening Process
Initial Consultation & Risk Assessment
Comprehensive review of your medical history, family history, lifestyle factors, and current symptoms. We calculate your baseline cardiovascular risk using advanced algorithms that go beyond traditional risk scores.
Advanced Blood Biomarker Testing
Detailed analysis of lipid particles, inflammatory markers, cardiac biomarkers, and metabolic health indicators. These tests provide insights that standard cholesterol panels miss.
Vascular Function Testing
Non-invasive assessment of endothelial function, arterial stiffness, and blood pressure dynamics. These measurements reveal early vascular ageing and dysfunction.
Cardiac Imaging Studies
Coronary calcium scoring to quantify atherosclerotic plaque burden, carotid ultrasound to assess arterial wall thickness, and echocardiography to evaluate cardiac structure and function.
Results Consultation
In-depth review of all findings with our cardiovascular specialist. We explain what your results mean, your absolute risk of cardiovascular events, and areas requiring intervention.
Personalised Prevention Plan
Development of a tailored strategy combining lifestyle optimization (nutrition, exercise, stress management), targeted supplementation, and medical therapies when indicated.
Ongoing Monitoring
Regular follow-up testing to track changes in biomarkers and imaging findings, ensuring your prevention strategy is working and adjusting interventions as needed.
Who Should Consider Cardiovascular Screening?
Whilst everyone benefits from understanding their cardiovascular health status, screening is particularly important for individuals with risk factors that increase the likelihood of developing heart disease or stroke.
Key Risk Factors
Even without traditional risk factors, individuals interested in longevity optimization benefit from baseline cardiovascular assessment to establish a reference point and guide prevention strategies.
From Screening to Prevention
Cardiovascular screening is only valuable if it leads to action. When we identify risk factors or early disease, we develop a comprehensive prevention strategy tailored to your specific findings.
Lifestyle Optimization: Targeted dietary interventions to reduce inflammation and improve lipid profiles, structured exercise programmes to enhance cardiovascular fitness and vascular function, stress management techniques to reduce sympathetic nervous system activation, and sleep optimization to support cardiovascular repair processes.
Medical Therapies: When indicated, we prescribe evidence-based medications to reduce cardiovascular risk. This may include statins or PCSK9 inhibitors for lipid management, antihypertensive medications for blood pressure control, antiplatelet agents for thrombosis prevention, and anti-inflammatory therapies for individuals with elevated inflammatory markers.
Regenerative Interventions: For selected patients, we offer advanced therapies including NAD+ infusions to support mitochondrial function and vascular health, peptide therapy to promote endothelial repair, and targeted supplementation with compounds that support cardiovascular function and reduce oxidative stress.
Ongoing Monitoring: Regular follow-up testing tracks the effectiveness of interventions. We monitor biomarkers to ensure lipid targets are achieved, repeat imaging studies to assess plaque progression or regression, and adjust strategies based on your response to treatment.
Frequently Asked Questions
Why is coronary calcium scoring important?
Coronary artery calcium (CAC) scoring directly measures atherosclerotic plaque in your coronary arteries. A CAC score of zero indicates very low risk, whilst elevated scores reveal significant plaque burden requiring aggressive intervention. CAC scoring improves risk prediction beyond traditional risk factors and helps guide treatment decisions, particularly for individuals in intermediate risk categories.
How does this differ from a standard health check?
Standard health checks typically measure total cholesterol, LDL, HDL, and triglycerides—basic markers that miss much of the cardiovascular risk picture. Our comprehensive screening includes advanced lipid particle analysis, inflammatory markers, cardiac biomarkers, vascular function testing, and imaging studies that reveal early disease before symptoms appear. This depth of assessment allows for earlier and more targeted intervention.
What if my screening reveals cardiovascular disease?
If we identify atherosclerosis, arterial dysfunction, or other cardiovascular abnormalities, we develop an intensive prevention and treatment plan. This may include optimisation of lipid levels through lifestyle and medication, anti-inflammatory interventions, blood pressure management, and in some cases regenerative therapies. Early detection allows us to slow or halt disease progression before it causes heart attack or stroke.
How often should cardiovascular screening be repeated?
Screening frequency depends on your baseline risk and findings. Individuals with low risk and normal results may repeat comprehensive screening every 3-5 years. Those with elevated risk, abnormal findings, or active interventions typically require annual monitoring of biomarkers and repeat imaging every 2-3 years to track disease progression or regression.